Position in MYGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,768,858
New position
Shares Held
1,535,702
first reported quarter
Ownership
1.61%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 196 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $567,039,905 across 20 Diagnostics & Research names. MYGN ranks #10 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
1,044,132 | $198,886,263 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
331,992 | $166,447,509 | |
| 3 | DGX |
Quest Diagnostics Inc
|
333,295 | $70,641,875 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
44,162 | $23,248,643 | |
| 5 | CSTL |
Castle Biosciences Inc
|
793,507 | $18,925,141 | |
| 6 | NTRA |
Natera, Inc.
|
53,116 | $14,418,338 | |
| 7 | A |
Agilent Technologies, Inc.
|
90,705 | $12,048,345 | |
| 8 | LH |
Labcorp Holdings Inc.
|
35,179 | $9,850,120 |
All Filings in MYGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,768,858 | 1,535,702 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||